Related Experiment Video
Updated: Jan 20, 2026

Subdural Soft Electrocorticography ECoG Array Implantation and Long-Term Cortical Recording in Minipigs
Published on: March 31, 2023
Implantable cardioverter-defibrillator in Brugada syndrome: Long-term follow-up
Ibrahim El-Battrawy1,2, Gretje Roterberg1, Volker Liebe1
1First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany.
Insights
Implantable cardioverter-defibrillators (ICDs) are used for Brugada syndrome (BrS) patients at risk of sudden cardiac death. However, ICDs carry risks of complications, including inappropriate shocks, particularly in symptomatic BrS patients.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Brugada syndrome (BrS) is a genetic disorder associated with an increased risk of sudden cardiac death (SCD).
- Implantable cardioverter-defibrillators (ICDs) are a recommended treatment for BrS patients to prevent SCD.
- Long-term outcomes and complication data for ICDs in BrS patients remain a subject of debate.
Purpose of the Study:
- To systematically review and analyze the outcomes and complications of ICD implantation in patients diagnosed with Brugada syndrome.
- To evaluate the incidence of appropriate and inappropriate shocks, as well as device-related complications in a large cohort of BrS patients.
Main Methods:
- A systematic literature review was conducted using major databases: PubMed, Web of Science, Cochrane Library, and Cinahl.
- Data from 11 studies, encompassing 747 BrS patients who received ICDs, were assimilated and analyzed.
Main Results:
- The study analyzed 747 Brugada syndrome patients (mean age 43.1 years, 82.5% male) receiving ICDs.
- Appropriate shocks occurred in 18.1% of patients over an average follow-up of 82.3 months. Device complications included lead failure (5.4%) and infection (3.9%).
- Inappropriate shocks were also documented in 18.1% of patients, with management strategies including pulmonary vein isolation and drug therapy.
Conclusions:
- ICD therapy in Brugada syndrome patients is associated with significant device-related complications.
- A substantial risk of inappropriate shocks was observed, particularly in symptomatic BrS patients.
- The findings highlight the need for careful patient selection and monitoring in BrS patients with ICDs.
Background:
Brugada syndrome (BrS) is associated with sudden cardiac death (SCD). Although implantable cardioverter-defibrillator (ICD) implantation is recommended, the long-term outcomes and follow-up data with regard to ICD complications have led to controversy.
Hypothesis:
In the present study, we described the data assimilated in a total of 11 studies, analyzing the outcome in 747 BrS patients receiving ICD.
Methods:
Data were performed and analyzed after a systematic review of literature compiled from a thorough database search (PubMed, Web of Science, Cochrane Library, and Cinahl).
Results:
The mean age of patients receiving ICD was (43.1 ± 13.4, 82.5% males, 46.6% spontaneous BrS type I). Around 15.3% of the patients were admitted due to SCD and 10.4% suffered from atrial arrhythmia. Appropriate shocks were documented in 18.1% of the patients over a mean follow-up period of 82.3 months (47.5-110.4). The following complications were recorded: lead failure and fracture (5.4%), lead perforation (0.7%), lead dislodgement (1.7%), infection (3.9%), pain (0.4%), subclavian vein thrombosis (0.3%), pericardial effusion (0.1%), endocarditis (0.1%), psychiatric problems (1.5%), pneumothorax (0.7%). Inappropriate shocks were documented in 18.1% of the patients. The management of inappropriate shocks was achieved by pulmonary vein isolation (0.5%), drug treatment with sotalol (1.3%) or sotalol with beta-blocker (0.3%) and hydroquinidine (0.1%).
Conclusions:
ICD therapy in BrS is associated with relevant ICD-related complications including a substantial risk of inappropriate shocks more frequently in symptomatic BrS patients.
More Related Videos
Related Concept Videos
Long-term Depression
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Nephrotic Syndrome I : Introduction
Directional Terms
Long-term Potentiation
Hebbian LTP
LTP can occur when...
Long-term Potentiation

